CASE Op-Ed: Don’t Punish Main Street for Sins of Wall Street
GERARD SCIMECA – Chairman, CASE March 4, 2018 – http://bit.ly/2te85ch One of the enduring truths of life is that it...
GERARD SCIMECA – Chairman, CASE March 4, 2018 – http://bit.ly/2te85ch One of the enduring truths of life is that it...
Matthew Kandrach – President, CASE February 19, 2018 – bit.ly/2Hu9HSv In the Trump era, it is downright astounding how quickly the...
President Trump has done a tremendous job in his first year in office in taking a machete to the unwieldy...
Matthew Kandrach – President, CASE Feb 15, 2018, 7:00 AM – http://washex.am/2CmQ2jr Many Americans now pay more for their healthcare through increased out-of-pocket...
This week marks the 22st anniversary of the Communications Act of 1996, the law that governs the rules for how...
As the federal ban on sports wagering looks to be on its final legs, legislation is finally moving through the...
The Sierra Club bills itself as “the nation’s largest and most influential grassroots environmental organization,” supposedly standing up for the...
MATTHEW KANDRACH President, CASE January 19, 2018 http://bit.ly/2DpweRV Though President Trump has yet to give our nation’s onerous regulatory state...
January 5, 2018 http://bit.ly/2EkdMWY By Gerard Scimeca, Chairman, CASE Judging by what feels like the 25th Star Wars sequel (or is it...
BY GERARD SCIMECA, CASE CHAIRMAN — December 18, 2017 http://bit.ly/2B9sbIj Abraham Lincoln said the best way to get a bad law...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/
© 2025 · Case for Consumers